penicillin and streptomycin (MultiCell Technologies)
90
Structured Review
MultiCell Technologies
penicillin and streptomycin
Penicillin And Streptomycin, supplied by MultiCell Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multicell/penicillin+streptomycin/pm21081647-280-48-49
Average 90 stars, based on 1 article reviews
Penicillin And Streptomycin, supplied by MultiCell Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multicell/penicillin+streptomycin/pm21081647-280-48-49
Average 90 stars, based on 1 article reviews
penicillin and streptomycin - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Modification:Article Title: Isolation and characterization of thymoquinone from <i>Nigella sativa</i> essential oil: antioxidant and antibacterial activities, molecular modeling studies, and cytotoxic effects on lung cancer A549 cells Article Snippet: Human alveolar adenocarcinoma cells A549 (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Capricorn) supplemented with 10% fetal bovine serum (FBS, Sigma) and 1% Article Title: Combining SMN2 splicing modifiers with HDAC6 inhibition greatly improves muscle function and survival in Spinal Muscular Atrophy Article Snippet: Cells were seeded on matrigel-coated (matrigel® matrix, Corning) 35 mm diameter plates and were maintained as myoblasts in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum and 1% Article Title: Microneedles with Implantable Tip‐Accumulated Therapeutics for the Long‐Term Management of Psoriasis Article Snippet: Dulbecco's Modified Eagle Medium (DMEM), fetal bovine serum (FBS), 1X phosphate‐buffered saline (PBS), and Article Title: Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo Article Snippet: HT-1080 cells (fibrosarcoma, male) and HeLa cells (adenocarcinoma, female) were grown at 37°C with 5% CO 2 in Dulbecco’s modified Eagle’s medium (DMEM; Multicell Technologies) supplemented with 1% Article Title: Modified Au:Fe-Ni magnetic micromotors improve drug delivery and diagnosis in MCF-7 cells and spheroids. Article Snippet: Nano/micromotors hold immense potential for revolutionizing drug delivery and detection systems, especially in the realm of cancer diagnosis and treatment, owing to their distinctive features, including precise propulsion, maneuverability, and meticulously designed surface modifications.. In this study, we explore the capabilities of modified and magnetically driven micromotors as active drug delivery systems within 2D and 3D cell culture environments and cancer diagnosis.. We synthesized gold (Au) and iron-nickel (Fe-Ni) metallic-based magnetic micromotors (Au:Fe-Ni MMs) through electrochemical methods, equipping them with functionalities for controlled doxorubicin (DOX) release and cancer cell recognition. Article Title: Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo. Article Snippet: HT-1080 cells (fibrosarcoma, male) and HeLa cells (adenocarcinoma, female) were grown at 37 Cwith 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM; Multicell Technologies) supplemented with 1% Article Title: Machine learning predictions of T cell antigen specificity from intracellular calcium dynamics Article Snippet: Bone marrow cells (1 × 10 6 ), harvested from the indicated mice (male and female, 6 to 12 weeks old), are plated in six-well adherent plates for 7 days in 4 ml of 10% fetal bovine serum (HyClone, catalog no. SH30396.03), 100 mM Article Title: Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy. Article Snippet: Immune checkpoint blockade therapy represented by programmed cell death ligand 1 (PD-L1) inhibitor for advanced renal carcinoma with an objective response rate (ORR) in patients is less than 20%.. It is attributed to abundant tumoral vasculature with abnormal structure limiting effector T cell infiltration and drug penetration.. We propose a bispecific fibrous glue (BFG) to regulate tumor immune and vascular microenvironments simultaneously. Saline:Article Title: Isolation and characterization of thymoquinone from <i>Nigella sativa</i> essential oil: antioxidant and antibacterial activities, molecular modeling studies, and cytotoxic effects on lung cancer A549 cells Article Snippet: Human alveolar adenocarcinoma cells A549 (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Capricorn) supplemented with 10% fetal bovine serum (FBS, Sigma) and 1% Article Title: Combining SMN2 splicing modifiers with HDAC6 inhibition greatly improves muscle function and survival in Spinal Muscular Atrophy Article Snippet: Cells were seeded on matrigel-coated (matrigel® matrix, Corning) 35 mm diameter plates and were maintained as myoblasts in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum and 1% Article Title: Microneedles with Implantable Tip‐Accumulated Therapeutics for the Long‐Term Management of Psoriasis Article Snippet: Dulbecco's Modified Eagle Medium (DMEM), fetal bovine serum (FBS), 1X phosphate‐buffered saline (PBS), and Article Title: Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo Article Snippet: HT-1080 cells (fibrosarcoma, male) and HeLa cells (adenocarcinoma, female) were grown at 37°C with 5% CO 2 in Dulbecco’s modified Eagle’s medium (DMEM; Multicell Technologies) supplemented with 1% Article Title: Modified Au:Fe-Ni magnetic micromotors improve drug delivery and diagnosis in MCF-7 cells and spheroids. Article Snippet: Nano/micromotors hold immense potential for revolutionizing drug delivery and detection systems, especially in the realm of cancer diagnosis and treatment, owing to their distinctive features, including precise propulsion, maneuverability, and meticulously designed surface modifications.. In this study, we explore the capabilities of modified and magnetically driven micromotors as active drug delivery systems within 2D and 3D cell culture environments and cancer diagnosis.. We synthesized gold (Au) and iron-nickel (Fe-Ni) metallic-based magnetic micromotors (Au:Fe-Ni MMs) through electrochemical methods, equipping them with functionalities for controlled doxorubicin (DOX) release and cancer cell recognition. Article Title: Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo. Article Snippet: HT-1080 cells (fibrosarcoma, male) and HeLa cells (adenocarcinoma, female) were grown at 37 Cwith 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM; Multicell Technologies) supplemented with 1% Article Title: Machine learning predictions of T cell antigen specificity from intracellular calcium dynamics Article Snippet: Bone marrow cells (1 × 10 6 ), harvested from the indicated mice (male and female, 6 to 12 weeks old), are plated in six-well adherent plates for 7 days in 4 ml of 10% fetal bovine serum (HyClone, catalog no. SH30396.03), 100 mM Article Title: Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy. Article Snippet: Immune checkpoint blockade therapy represented by programmed cell death ligand 1 (PD-L1) inhibitor for advanced renal carcinoma with an objective response rate (ORR) in patients is less than 20%.. It is attributed to abundant tumoral vasculature with abnormal structure limiting effector T cell infiltration and drug penetration.. We propose a bispecific fibrous glue (BFG) to regulate tumor immune and vascular microenvironments simultaneously. Cell Culture:Article Title: Isolation and characterization of thymoquinone from <i>Nigella sativa</i> essential oil: antioxidant and antibacterial activities, molecular modeling studies, and cytotoxic effects on lung cancer A549 cells Article Snippet: Human alveolar adenocarcinoma cells A549 (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Capricorn) supplemented with 10% fetal bovine serum (FBS, Sigma) and 1% Article Title: Combining SMN2 splicing modifiers with HDAC6 inhibition greatly improves muscle function and survival in Spinal Muscular Atrophy Article Snippet: Cells were seeded on matrigel-coated (matrigel® matrix, Corning) 35 mm diameter plates and were maintained as myoblasts in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum and 1% Article Title: Microneedles with Implantable Tip‐Accumulated Therapeutics for the Long‐Term Management of Psoriasis Article Snippet: Dulbecco's Modified Eagle Medium (DMEM), fetal bovine serum (FBS), 1X phosphate‐buffered saline (PBS), and Article Title: Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo Article Snippet: HT-1080 cells (fibrosarcoma, male) and HeLa cells (adenocarcinoma, female) were grown at 37°C with 5% CO 2 in Dulbecco’s modified Eagle’s medium (DMEM; Multicell Technologies) supplemented with 1% Article Title: Modified Au:Fe-Ni magnetic micromotors improve drug delivery and diagnosis in MCF-7 cells and spheroids. Article Snippet: Nano/micromotors hold immense potential for revolutionizing drug delivery and detection systems, especially in the realm of cancer diagnosis and treatment, owing to their distinctive features, including precise propulsion, maneuverability, and meticulously designed surface modifications.. In this study, we explore the capabilities of modified and magnetically driven micromotors as active drug delivery systems within 2D and 3D cell culture environments and cancer diagnosis.. We synthesized gold (Au) and iron-nickel (Fe-Ni) metallic-based magnetic micromotors (Au:Fe-Ni MMs) through electrochemical methods, equipping them with functionalities for controlled doxorubicin (DOX) release and cancer cell recognition. Article Title: Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo. Article Snippet: HT-1080 cells (fibrosarcoma, male) and HeLa cells (adenocarcinoma, female) were grown at 37 Cwith 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM; Multicell Technologies) supplemented with 1% Article Title: Machine learning predictions of T cell antigen specificity from intracellular calcium dynamics Article Snippet: Bone marrow cells (1 × 10 6 ), harvested from the indicated mice (male and female, 6 to 12 weeks old), are plated in six-well adherent plates for 7 days in 4 ml of 10% fetal bovine serum (HyClone, catalog no. SH30396.03), 100 mM Article Title: Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy. Article Snippet: Immune checkpoint blockade therapy represented by programmed cell death ligand 1 (PD-L1) inhibitor for advanced renal carcinoma with an objective response rate (ORR) in patients is less than 20%.. It is attributed to abundant tumoral vasculature with abnormal structure limiting effector T cell infiltration and drug penetration.. We propose a bispecific fibrous glue (BFG) to regulate tumor immune and vascular microenvironments simultaneously. Imaging:Article Title: Isolation and characterization of thymoquinone from <i>Nigella sativa</i> essential oil: antioxidant and antibacterial activities, molecular modeling studies, and cytotoxic effects on lung cancer A549 cells Article Snippet: Human alveolar adenocarcinoma cells A549 (ATCC) were cultured in Dulbecco's modified Eagle's medium (DMEM, Capricorn) supplemented with 10% fetal bovine serum (FBS, Sigma) and 1% Article Title: Combining SMN2 splicing modifiers with HDAC6 inhibition greatly improves muscle function and survival in Spinal Muscular Atrophy Article Snippet: Cells were seeded on matrigel-coated (matrigel® matrix, Corning) 35 mm diameter plates and were maintained as myoblasts in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum and 1% Article Title: Microneedles with Implantable Tip‐Accumulated Therapeutics for the Long‐Term Management of Psoriasis Article Snippet: Dulbecco's Modified Eagle Medium (DMEM), fetal bovine serum (FBS), 1X phosphate‐buffered saline (PBS), and Article Title: Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo Article Snippet: HT-1080 cells (fibrosarcoma, male) and HeLa cells (adenocarcinoma, female) were grown at 37°C with 5% CO 2 in Dulbecco’s modified Eagle’s medium (DMEM; Multicell Technologies) supplemented with 1% Article Title: Modified Au:Fe-Ni magnetic micromotors improve drug delivery and diagnosis in MCF-7 cells and spheroids. Article Snippet: Nano/micromotors hold immense potential for revolutionizing drug delivery and detection systems, especially in the realm of cancer diagnosis and treatment, owing to their distinctive features, including precise propulsion, maneuverability, and meticulously designed surface modifications.. In this study, we explore the capabilities of modified and magnetically driven micromotors as active drug delivery systems within 2D and 3D cell culture environments and cancer diagnosis.. We synthesized gold (Au) and iron-nickel (Fe-Ni) metallic-based magnetic micromotors (Au:Fe-Ni MMs) through electrochemical methods, equipping them with functionalities for controlled doxorubicin (DOX) release and cancer cell recognition. Article Title: Exploiting the endogenous yeast nuclear proteome to identify short linear motifs in vivo. Article Snippet: HT-1080 cells (fibrosarcoma, male) and HeLa cells (adenocarcinoma, female) were grown at 37 Cwith 5% CO2 in Dulbecco’s modified Eagle’s medium (DMEM; Multicell Technologies) supplemented with 1% Article Title: Machine learning predictions of T cell antigen specificity from intracellular calcium dynamics Article Snippet: Bone marrow cells (1 × 10 6 ), harvested from the indicated mice (male and female, 6 to 12 weeks old), are plated in six-well adherent plates for 7 days in 4 ml of 10% fetal bovine serum (HyClone, catalog no. SH30396.03), 100 mM Article Title: Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy. Article Snippet: Immune checkpoint blockade therapy represented by programmed cell death ligand 1 (PD-L1) inhibitor for advanced renal carcinoma with an objective response rate (ORR) in patients is less than 20%.. It is attributed to abundant tumoral vasculature with abnormal structure limiting effector T cell infiltration and drug penetration.. We propose a bispecific fibrous glue (BFG) to regulate tumor immune and vascular microenvironments simultaneously. |